Literature DB >> 26507119

Epigenetic instability at imprinting control regions in a Kras(G12D)-induced T-cell neoplasm.

Corey L Bretz1, Ingeborg M Langohr2, Suman Lee1, Joomyeong Kim1.   

Abstract

Although aberrant DNA methylation within imprinted domains has been reported in a variety of neoplastic diseases, it remains largely uncharacterized in the context of carcinogenesis. In this study, we induced T-cell lymphoma in mice by employing a breeding scheme involving mouse strains, LSL-Kras(G12D) and MMTV-Cre. We then systematically surveyed imprinted domains for DNA methylation changes during tumor progression using combined bisulfite restriction analysis and NGS-based bisulfite sequencing. We detected hyper- or hypo-methylation at the imprinting control regions (ICRs) of the Dlk1, Peg10, Peg3, Grb10, and Gnas domains. These DNA methylation changes at ICRs were more prevalent and consistent than those observed at the promoter regions of well-known tumor suppressors, such as Mgmt, Fhit, and Mlh1. Thus, the changes observed at these imprinted domains are the outcome of isolated incidents affecting DNA methylation settings. Within imprinted domains, DNA methylation changes tend to be restricted to ICRs as nearby somatic differentially methylated regions and promoter regions experience no change. Furthermore, detailed analyses revealed that small cis-regulatory elements within ICRs tend to be resistant to DNA methylation changes, suggesting potential protection by unknown trans-factors. Overall, this study demonstrates that DNA methylation changes at ICRs are dynamic during carcinogenesis and advocates that detection of aberrant DNA methylation at ICRs may serve as a biomarker to enhance diagnostic procedures.

Entities:  

Keywords:  DNA methylation; T-cell lymphoma; cancer; genomic imprinting; imprinting control regions

Mesh:

Substances:

Year:  2015        PMID: 26507119      PMCID: PMC4844204          DOI: 10.1080/15592294.2015.1110672

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  35 in total

1.  DNA methylation of transcriptional enhancers and cancer predisposition.

Authors:  Dvir Aran; Asaf Hellman
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

Review 2.  Genomic imprinting in mammals.

Authors:  Denise P Barlow; Marisa S Bartolomei
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-02-01       Impact factor: 10.005

Review 3.  Mammalian genomic imprinting.

Authors:  Marisa S Bartolomei; Anne C Ferguson-Smith
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

4.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

5.  Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation.

Authors:  Guangyao Kong; Juan Du; Yangang Liu; Benjamin Meline; Yuan-I Chang; Erik A Ranheim; Jinyong Wang; Jing Zhang
Journal:  J Biol Chem       Date:  2013-05-14       Impact factor: 5.157

6.  Sp1 elements protect a CpG island from de novo methylation.

Authors:  M Brandeis; D Frank; I Keshet; Z Siegfried; M Mendelsohn; A Nemes; V Temper; A Razin; H Cedar
Journal:  Nature       Date:  1994-09-29       Impact factor: 49.962

7.  Peg3 mutational effects on reproduction and placenta-specific gene families.

Authors:  Joomyeong Kim; Wesley D Frey; Hongzhi He; Hana Kim; Muhammad B Ekram; Arundhati Bakshi; Mohammad Faisal; Bambarendage P U Perera; An Ye; Ryoichi Teruyama
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

8.  Yy1 gene dosage effect and bi-allelic expression of Peg3.

Authors:  Bambarendage P U Perera; Ryoichi Teruyama; Joomyeong Kim
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

9.  Identification of an evolutionarily conserved cis-regulatory element controlling the Peg3 imprinted domain.

Authors:  Michelle M Thiaville; Hana Kim; Wesley D Frey; Joomyeong Kim
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

10.  DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes.

Authors:  Dvir Aran; Sivan Sabato; Asaf Hellman
Journal:  Genome Biol       Date:  2013-03-12       Impact factor: 13.583

View more
  5 in total

1.  Intergenic and intronic DNA hypomethylated regions as putative regulators of imprinted domains.

Authors:  Arundhati Bakshi; Corey L Bretz; Terri L Cain; Joomyeong Kim
Journal:  Epigenomics       Date:  2018-03-23       Impact factor: 4.778

2.  Phylogenetic and Epigenetic Footprinting of the Putative Enhancers of the Peg3 Domain.

Authors:  Joomyeong Kim; An Ye
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

3.  RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.

Authors:  Daniel B Lipka; Tania Witte; Reka Toth; Jing Yang; Manuel Wiesenfarth; Peter Nöllke; Alexandra Fischer; David Brocks; Zuguang Gu; Jeongbin Park; Brigitte Strahm; Marcin Wlodarski; Ayami Yoshimi; Rainer Claus; Michael Lübbert; Hauke Busch; Melanie Boerries; Mark Hartmann; Maximilian Schönung; Umut Kilik; Jens Langstein; Justyna A Wierzbinska; Caroline Pabst; Swati Garg; Albert Catalá; Barbara De Moerloose; Michael Dworzak; Henrik Hasle; Franco Locatelli; Riccardo Masetti; Markus Schmugge; Owen Smith; Jan Stary; Marek Ussowicz; Marry M van den Heuvel-Eibrink; Yassen Assenov; Matthias Schlesner; Charlotte Niemeyer; Christian Flotho; Christoph Plass
Journal:  Nat Commun       Date:  2017-12-19       Impact factor: 14.919

4.  PTPN11 mutation with additional somatic alteration indicates unfavorable outcome in juvenile myelomonocytic leukemia: a retrospective clinical study from a single center.

Authors:  Yan Miao; Benshang Li; Lixia Ding; Hua Zhu; Changying Luo; Jianmin Wang; Chengjuan Luo; Jing Chen
Journal:  Eur J Pediatr       Date:  2019-12-05       Impact factor: 3.183

5.  Epigenetic response of imprinted domains during carcinogenesis.

Authors:  Corey L Bretz; Ingeborg M Langohr; Joomyeong Kim
Journal:  Clin Epigenetics       Date:  2017-08-25       Impact factor: 6.551

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.